Dodge & Cox’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $119M | Sell |
759,373
-6,208,010
| -89% | -$931M | 0.06% | 105 |
|
|
2026
Q1 | $1.06B | Sell |
6,967,383
-2,047,258
| -23% | -$314M | 0.58% | 63 |
|
|
2025
Q4 | $1.24B | Sell |
9,014,641
-1,570,504
| -15% | -$206M | 0.67% | 54 |
|
|
2025
Q3 | $1.36B | Sell |
10,585,145
-62,484
| -0.6% | -$7.62M | 0.73% | 48 |
|
|
2025
Q2 | $1.29B | Sell |
10,647,629
-1,170,473
| -10% | -$132M | 0.72% | 47 |
|
|
2025
Q1 | $1.32B | Sell |
11,818,102
-396,563
| -3% | -$42.2M | 0.75% | 50 |
|
|
2024
Q4 | $1.19B | Sell |
12,214,665
-7,211
| -0.1% | -$769K | 0.69% | 51 |
|
|
2024
Q3 | $1.41B | Sell |
12,221,876
-14,650
| -0.1% | -$1.66M | 0.8% | 48 |
|
|
2024
Q2 | $1.3B | Sell |
12,236,526
-117,459
| -1% | -$11.8M | 0.78% | 45 |
|
|
2024
Q1 | $1.2B | Sell |
12,353,985
-811,553
| -6% | -$83.2M | 0.69% | 53 |
|
|
2023
Q4 | $1.33B | Sell |
13,165,538
-3,098,683
| -19% | -$299M | 0.84% | 47 |
|
|
2023
Q3 | $1.66B | Sell |
16,264,221
-142,892
| -0.9% | -$14.5M | 1.12% | 32 |
|
|
2023
Q2 | $1.66B | Sell |
16,407,113
-3,905,567
| -19% | -$391M | 1.1% | 30 |
|
|
2023
Q1 | $1.87B | Sell |
20,312,680
-438,692
| -2% | -$38.3M | 1.27% | 29 |
|
|
2022
Q4 | $1.88B | Sell |
20,751,372
-297,285
| -1% | -$25M | 1.29% | 24 |
|
|
2022
Q3 | $1.6B | Sell |
21,048,657
-1,504,112
| -7% | -$125M | 1.21% | 29 |
|
|
2022
Q2 | $1.91B | Sell |
22,552,769
-5,291,440
| -19% | -$464M | 1.32% | 28 |
|
|
2022
Q1 | $2.44B | Sell |
27,844,209
-405,331
| -1% | -$35.1M | 1.48% | 24 |
|
|
2021
Q4 | $2.47B | Sell |
28,249,540
-1,016,360
| -3% | -$84.4M | 1.53% | 27 |
|
|
2021
Q3 | $2.39B | Buy |
29,265,900
+4,812,635
| +20% | +$433M | 1.56% | 26 |
|
|
2021
Q2 | $2.23B | Buy |
24,453,265
+2,783,028
| +13% | +$248M | 1.46% | 24 |
|
|
2021
Q1 | $1.85B | Buy |
21,670,237
+54,436
| +0.3% | +$4.88M | 1.32% | 28 |
|
|
2020
Q4 | $2.04B | Sell |
21,615,801
-175,374
| -0.8% | -$15.3M | 1.61% | 23 |
|
|
2020
Q3 | $1.89B | Buy |
21,791,175
+2,437,388
| +13% | +$211M | 1.73% | 22 |
|
|
2020
Q2 | $1.69B | Sell |
19,353,787
-3,587,653
| -16% | -$310M | 1.55% | 24 |
|
|
2020
Q1 | $1.89B | Sell |
22,941,440
-2,264,141
| -9% | -$202M | 2.05% | 20 |
|
|
2019
Q4 | $2.39B | Sell |
25,205,581
-1,563,295
| -6% | -$140M | 1.83% | 22 |
|
|
2019
Q3 | $2.33B | Sell |
26,768,876
-2,655,693
| -9% | -$238M | 1.91% | 20 |
|
|
2019
Q2 | $2.69B | Sell |
29,424,569
-11,135,999
| -27% | -$942M | 2.17% | 15 |
|
|
2019
Q1 | $3.49B | Sell |
40,560,568
-506,690
| -1% | -$40.7M | 2.87% | 8 |
|
|
2018
Q4 | $3.16B | Sell |
41,067,258
-8,440,050
| -17% | -$657M | 2.89% | 5 |
|
|
2018
Q3 | $3.82B | Buy |
49,507,308
+256,150
| +0.5% | +$18.9M | 2.92% | 5 |
|
|
2018
Q2 | $3.33B | Sell |
49,251,158
-187,823
| -0.4% | -$13M | 2.66% | 11 |
|
|
2018
Q1 | $3.58B | Sell |
49,438,981
-311,615
| -0.6% | -$23.7M | 2.89% | 6 |
|
|
2017
Q4 | $3.74B | Sell |
49,750,596
-72,024
| -0.1% | -$5.43M | 2.9% | 5 |
|
|
2017
Q3 | $3.83B | Sell |
49,822,620
-6,137,536
| -11% | -$464M | 3.08% | 4 |
|
|
2017
Q2 | $4.19B | Sell |
55,960,156
-493,586
| -0.9% | -$35M | 3.53% | 1 |
|
|
2017
Q1 | $3.76B | Buy |
56,453,742
+5,431,873
| +11% | +$362M | 3.19% | 6 |
|
|
2016
Q4 | $3.33B | Buy |
51,021,869
+2,384,484
| +5% | +$155M | 2.96% | 8 |
|
|
2016
Q3 | $3.44B | Sell |
48,637,385
-875,641
| -2% | -$63.8M | 3.23% | 5 |
|
|
2016
Q2 | $3.66B | Sell |
49,513,026
-768,260
| -2% | -$53.1M | 3.62% | 3 |
|
|
2016
Q1 | $3.26B | Sell |
50,281,286
-58,221
| -0.1% | -$3.96M | 3.19% | 6 |
|
|
2015
Q4 | $3.88B | Sell |
50,339,507
-687,400
| -1% | -$54.6M | 3.81% | 2 |
|
|
2015
Q3 | $4.2B | Sell |
51,026,907
-2,507,998
| -5% | -$223M | 4.23% | 3 |
|
|
2015
Q2 | $4.72B | Sell |
53,534,905
-2,301,694
| -4% | -$211M | 4.25% | 3 |
|
|
2015
Q1 | $4.93B | Sell |
55,836,599
-325,705
| -0.6% | -$28.9M | 4.55% | 2 |
|
|
2014
Q4 | $4.66B | Sell |
56,162,304
-648,177
| -1% | -$53.7M | 4.33% | 2 |
|
|
2014
Q3 | $4.79B | Sell |
56,810,481
-219,595
| -0.4% | -$17.8M | 4.58% | 2 |
|
|
2014
Q2 | $4.63B | Buy |
57,030,076
+5,201,731
| +10% | +$409M | 4.41% | 2 |
|
|
2014
Q1 | $3.95B | Sell |
51,828,345
-49,308
| -0.1% | -$3.59M | 4.04% | 2 |
|
|
2013
Q4 | $3.74B | Sell |
51,877,653
-420,676
| -0.8% | -$29.2M | 3.9% | 2 |
|
|
2013
Q3 | $3.59B | Sell |
52,298,329
-323,841
| -0.6% | -$21.4M | 4.08% | 1 |
|
|
2013
Q2 | $3.33B | Buy |
+52,622,170
| New | +$3.42B | 3.96% | 2 |
|
Other funds holding NVS
Dodge & Cox's NVS Position: Q2 2026 in Review
Dodge & Cox reduced its Novartis (NVS) stake by 89% in Q2 2026, selling an estimated $931M and leaving 759,373 shares worth $119M. The position accounts for 0.06% of the portfolio, ranked #105.
Dodge & Cox first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.93B in Q1 2015. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Dodge & Cox held 759,373 shares of Novartis worth $119M as of Q2 2026.
- Dodge & Cox sold 6,208,010 Novartis shares in Q2 2026, an estimated $931M.
- Novartis made up 0.06% of Dodge & Cox's portfolio in Q2 2026, its #105 holding.
- Dodge & Cox first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- Dodge & Cox's Novartis position peaked at $4.93B in Q1 2015.
- 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Dodge & Cox's 13F filing for Q2 2026, filed 13 Aug 2026.